6/26/2013 More #Research Needs to Be Done On Treatment For #LungCancer Among Non-Smoking #WomenRead NowThis story originally published by Sam Goodwin on HGNG.com on 6/26/13. The International Association for the Study of Lung Cancer (IASLC) finds that much more research needs to be done on treatment given to non-smoking women for lung cancer. An estimated 516,000 women worldwide are affected by lung cancer and 100,000 of these women are from the United States. Up until now, women with lung cancer have been given the same treatment as men. However, numerous studies have highlighted different characteristics of lung cancer in women. Hence, there is a need for more research to be done on lung cancer treatment given to women, especially those who don't smoke, states the International Association for the Study of Lung Cancer (IASLC). Researchers from the University of Toulouse III in France looked into the clinical, pathological and biological characteristics of lung cancer in 140 women. They found that 63 participants had never smoked in their lives while 77 were either former or current smokers. Researchers compared the findings of both groups and found differential genetic alteration repartition in women according to their tobacco status. Around 50.8 percent of women who had never smoked displayed an EGFR mutation while only 10.4 percent of current/former smokers showed the same mutation. However, 33.8% of current/former smokers showed K-Ras mutation while only 9.5 percent of women who had never smoked showed this form of mutation. The researchers also observed a higher percentage of estrogen receptors (ER) α expression in patients who never smoked when compared with smokers. This led researchers to conclude that lung cancer in women who have never smoked is more frequently associated with EGFR mutations and estrogen receptor (ER) over expression. "These findings underline the possibility of treatment for women who have never smoked with drugs to target hormonal factors, genetic abnormalities, or both," the authors say. The study is published in the July issue of the Journal of Thoracic Oncology.
0 Comments
6/20/2013 The Bonnie J. Addario #LungCancer Foundation's 360 Community Hospital Program Improving Individualized Standard of Care for PatientsRead NowPilot program already showing positive patient outcomes, with ultimate goal to increase the lung cancer survival rate. SAN CARLOS, CALIF., JUNE 20, 2013 — /PRNewswire-USNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation is creating a new patient-focused approach to standard of care for lung cancer with the launch of the Patient 360 Community Hospital Program. The program uses a collaborative, multi-disciplinary model to provide an individualized approach to care, giving the patient access to the newest and most effective diagnostic and therapeutic techniques for their specific needs. "What we're finding is by using a team approach to individualized care we can begin to incrementally increase the survival rate of people diagnosed with lung cancer," said Bonnie J. Addario, a stage 3B survivor and founder of the Bonnie J. Addario Lung Cancer Foundation (LCF). "Because 80 percent of patients receive treatment at their local community hospital, these are the centers where the greatest good can be done for the greatest number." Working with an elite team of pathologists and specialists to create an unsurpassed paradigm for lung cancer treatment, the LCF is in essence creating lung-specific centers of excellence in the community hospital setting. The program ensures that every patient receives molecular testing, combined with a multi-disciplinary team approach and selected treatment options unique to the patient's needs. "The 360 Program's multidisciplinary approach is unique because it coordinates the standard of care for patients individually, giving each patient what's right for them." Addario said. "So the oncologist, the radiation oncologist, the pathologist, the pulmonologist, and the surgeon are all communicating and collaborating, not just with academic, industry and technology, but internally as well." During the first six months of the pilot stage of the program, preliminary metrics and data have shown that patient outcomes have improved dramatically.
The program is rigid in its standard of treatment. Every patient in the pilot 360 program received molecular testing to better determine personalized treatments, as will be the case for all future patients as the program expands to more community hospitals in the coming years. Three new hospitals are expected to enlist by the end of 2013 and 30-50 by the end of 2015. The program's process focuses on early detection, diagnosis, treatment and treatment monitoring, and patient follow up. Critical in the program's standard of care is ensuring all patients receive molecular testing, which uses DNA, RNA and proteins to test for specific states of disease. In lung cancer, molecular testing is used to determine potential patient response to targeted therapy. The LCF has received generous support from a number of distinguished industry partners, including GE Healthcare, Pfizer and Boehringer-Ingelheim. GE Healthcare provided in-kind services from its oncology solutions division to help create the program's flow and metrics. The LCF is working with Boehringer-Ingelheim and Pfizer in partnership to broaden the overall awareness of multi-disciplinary collaborations that incorporate personalized testing to initiate timely and appropriate lung cancer treatments. Boehringer-Ingelheim also leads the letstestnow.com campaign, set up to improve patient outcomes through a multidisciplinary approach to biomarker testing in advanced non-small cell lung cancer. "Every community hospital that joins us and implements this new multi-disciplinary, patient-centric approach to standard of care will be given a formal seal of excellence awarded by the LCF, signifying that no lung cancer patient is left behind," Addario said. The pilot program launches during a time when an estimated 228,190 new cases of lung cancer will be diagnosed in the United States this year. The American Cancer Society also estimates 159,480 Americans will die from the disease this year. The facts about Lung Cancer cannot continue to go unnoticed:
"The Foundation is powering progress through ground-up initiatives, educating patients to identify solutions and make timely and meaningful change," Addario said. "The LCF is empowering patients to take a seat at the table wherever discussions are being made about their care. We are committed to improving the standard of care and believe that chronically managed lung cancer using molecular testing to determine personalized therapies is the future of lung cancer treatment and the pathway to increasing the survival rate." About the Bonnie J. Addario Lung Cancer Foundation The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised more than $10 million for lung cancer research. SOURCE Bonnie J. Addario Lung Cancer Foundation 6/19/2013 Join Team "Jogging for Joan" at Free to Breathe Atlanta 5K Run/Walk on August 17th in Virginia Highlands!Read NowJogging for Joan is the team name in memory of Joan Gaeta and all those loved and lost to lung cancer for various run/walks held in North Georgia. The next lung cancer awareness run/walk is the Free to Breathe Atlanta event on August 17th in Virginia Highlands. Join our team today by clicking here! Location John Howell Park, Virginia Highlands Greencove and Virginia Ave. (near Inman Middle School) Atlanta, GA 30306 Event Schedule 7:00 a.m. - Registration & check-in 8:15 a.m. - Welcome rally 8:30 a.m. - Run begins 8:35 a.m. - Walks begin 9:15 a.m. - Awards ceremony & closing remarks Registration Fees/Deadlines
T-Shirts All online and mail-in registrants are guaranteed an event T-shirt. A limited quantity of T-shirts will be available for those registering on event day. Additional Activities There will be an honor/memory wall at the event and participants are welcome to bring photos, momentos and thoughts to share on it. Team Photos Don't miss out on the opportunity to capture and commemorate the spirit of your team on event day by heading over to the team photo area! Details about when and where will be available at registration/check-in the morning of the event. Advance Packet Pick-Up For your convenience, advance packet pick-up will be available on Aug. 16 at Fleet Feet Decatur (431 W. Ponce de Leon Ave., Decatur, GA 30030. Pick-up times will be announced as the event gets closer. Race Awards Awards will be presented to the top overall male and female finishers, the top overall masters (40+ years) male and female finishers and the top overall male and female finisher in the following age divisions: 14 & under, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64 and 65+. Course Description The certified 5K course winds through the tree-lined, frequently rolling hills of Virginia Highland, one of Atlanta's most interesting historic neighborhoods. The final quarter mile directs participants steadily uphill to the finish.
If you answered “yes,you may be eligible to participate in a study by a researcher at Capella University – your experience matters! Participation in this study involves a one-time interview, either in- person, by webcam or, if necessary, by telephone. A $10 gift card or a $10 donation to any lung cancer organization will be provided as compensation for your time. Please contact: Rachael at RBrandt@capellauniversity.edu for more information. 6/6/2013 Former NFL Stars Team Up to Beat Lung Cancer at the Eigth Annual "Lung Cancer: Drive It Off the Face of the Earth" Golf TournamentRead NowSAN CARLOS, Calif., June 5, 2013 /PRNewswire-USNewswire/ — Former NFL stars Hank Baskett and Chris Draft are joining hundreds of lung cancer supporters at the 8th Annual “Lung Cancer: Drive It Off the Earth” Golf Tournament hosted by the Bonnie J. Addario Lung Cancer Foundation (LCF). The LCF invites you to be part of this event and help surpass last year’s fundraising goals. The tournament will take place on Monday, June 10, 2013 at Green Hills Country Club in Millbrae, Calif. “Lung cancer affects everyone regardless of their social status, age, race or gender,” said Bonnie J. Addario , stage 3B lung cancer survivor and Founder of the LCF. “In the last 45 years, 50 million people worldwide have died from lung cancer and we can’t just sit back and let this continue. This tournament will raise much-needed awareness and funds for medical treatments and studies for lung cancer patients everywhere.” Lung cancer hits home for both Baskett and Draft, as it does for millions of others worldwide. Baskett, who played five years in the NFL with the Indianapolis Colts, Minnesota Vikings, and the Philadelphia Eagles, is helping his father battle the disease. When Baskett’s father was diagnosed with lung cancer in 2011 he struggled with treatment. After Hank was introduced to the LCF two years ago, they put him in touch with Dr. Ross Camidge of the University of Colorado, who was able to put Baskett’s father on a personalized treatment. Baskett’s father responded well to the treatment almost immediately and is living a full life today. Baskett recently hosted his own charity golf tournament in Rancho Palos Verdes and is committed to working with LCF to end this disease. Draft played 12 years in the NFL for the Chicago Bears, San Francisco 49ers, Atlanta Falcons, Carolina Panthers, St. Louis Rams and the Buffalo Bills. Draft lost his wife, who never smoked, to the disease last year and has been working with the LCF and Baskett to raise awareness about the leading cancer killer in the U.S. “We are excited to have Hank and Chris back again this year,” Addario said. “They are making bold statements against lung cancer on behalf of those affected by the disease, and they are demonstrating a passion for the LCF’s goal to help turn lung cancer into a manageable, survivable disease.” Whether on the football field, the golf course or in real life, Baskett and Draft are fighting to raise funds for research and are setting good examples for lung cancer patients in all stages. Golfers and supporters are encouraged to join them on the private, Dr. Alister MacKenzie -designed championship 18-hole course. They will also enjoy a fabulous day of blackjack, margaritas, putting contests, prizes, raffles, auctions and an amazing homemade BBQ buffet dinner. The awareness generated by this golf tournament can’t come at a more crucial time. In 2013 alone, an estimated 228,190 new cases of lung cancer will be diagnosed in the United States. And the American Cancer Society also estimates 159,480 Americans will die from the disease this year. The facts about Lung Cancer cannot continue to go unnoticed:
The LCF funds clinical research that leads to life-saving discoveries and treatments and provides critical support services and educational programs to empower patients, power progress and create hope. For sponsorship opportunities, please email golf@lungcancerfoundation.org or call (415) 821-9693. About the Bonnie J. Addario Lung Cancer Foundation The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, education, early detection, genetic testing, drug discovery and patient-focused outcomes. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised more than $10 million for lung cancer research. To learn more, please visit www.lungcancerfoundation.org. About The Chris Draft Family Foundation and Team Draft The Chris Draft Family Foundation is a 501(c) 3 non-profit corporation dedicated to strengthening communities by empowering families to live healthy lifestyles. The Foundation focuses on several initiatives with overarching themes that stress the importance of education, healthy lifestyles, character development, personal responsibility, self-discipline, and physical fitness. To learn more about the Chris Draft Family Foundation, please visit www.chrisdraftfamilyfoundation.org. SOURCE: Bonnie J. Addario Lung Cancer Foundation RELATED LINKS http://www.lungcancerfoundation.org |
Details
|